chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pruritus
Clinical narrative: burning foot; itching in right foot; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning foot) and PRURITUS (itching in right foot) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 002B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GLYBURIDE, LINAGLIPTIN (TRAJENTA), INSULIN DETEMIR (LEVEMIR) and LISINOPRIL for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced BURNING SENSATION (burning foot) and PRURITUS (itching in right foot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Burning foot and Itching, at a dose of 1 dosage form. At the time of the report, BURNING SENSATION (burning foot) and PRURITUS (itching in right foot) outcome was unknown. Not Provided          Concomitant medications include vitamins.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Insomnia, Vaccination site pain
Clinical narrative: sleeping difficulties; redness; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (sleeping difficulties), ERYTHEMA (redness) and VACCINATION SITE PAIN (injection site pain) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21H and 029A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE and QUETIAPINE FUMARATE (SEROQUEL) for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (injection site pain). On an unknown date, the patient experienced INSOMNIA (sleeping difficulties) and ERYTHEMA (redness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INSOMNIA (sleeping difficulties), ERYTHEMA (redness) and VACCINATION SITE PAIN (injection site pain) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: experiencing side effects; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (I am experiencing side effects i think) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I am experiencing side effects i think). At the time of the report, VACCINATION COMPLICATION (I am experiencing side effects i think) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported  Treatment information was not provided
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza, Nausea, Pain, Pyrexia
Clinical narrative: fever; chills; nausea; body aches; generally felt like I had the flu; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), PAIN (body aches) and INFLUENZA (generally felt like I had the flu) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), PAIN (body aches) and INFLUENZA (generally felt like I had the flu). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 09-Apr-2021, PYREXIA (fever), CHILLS (chills), NAUSEA (nausea), PAIN (body aches) and INFLUENZA (generally felt like I had the flu) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pollakiuria
Clinical narrative: Flu like symptoms; Frequent urination; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) and POLLAKIURIA (Frequent urination) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms) and POLLAKIURIA (Frequent urination). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) and POLLAKIURIA (Frequent urination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Myalgia, Vaccination site reaction, Vertigo positional
Clinical narrative: vertigo; flu-like symptoms; covid arm; COVID arm, full body aches; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO POSITIONAL (vertigo), MYALGIA (COVID arm, full body aches), INFLUENZA LIKE ILLNESS (flu-like symptoms) and VACCINATION SITE REACTION (covid arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01B21A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced MYALGIA (COVID arm, full body aches) and VACCINATION SITE REACTION (covid arm). On 10-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). On 11-Apr-2021, the patient experienced VERTIGO POSITIONAL (vertigo). The patient was treated with MECLIZINE HCL (oral) ongoing from 11-Apr-2021 for Vertigo, at a dose of 25 mg three times a day. On 09-Apr-2021, MYALGIA (COVID arm, full body aches) and VACCINATION SITE REACTION (covid arm) had resolved. On 11-Apr-2021, INFLUENZA LIKE ILLNESS (flu-like symptoms) had resolved. At the time of the report, VERTIGO POSITIONAL (vertigo) outcome was unknown. Not Provided          No concomitant medications provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dyspnoea, Faeces discoloured, Illness
Clinical narrative: I'm still sick; Diarrhoea; Weak; Shortness of breath; Back, tarry stool.; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I'm still sick), DIARRHOEA (Diarrhoea), ASTHENIA (Weak), DYSPNOEA (Shortness of breath) and FAECES DISCOLOURED (Back, tarry stool.) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and xx3A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE and HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/APAP) for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced ILLNESS (I'm still sick), DIARRHOEA (Diarrhoea), ASTHENIA (Weak) and FAECES DISCOLOURED (Back, tarry stool.). 10-Apr-2021, the patient experienced DYSPNOEA (Shortness of breath). The patient was treated with EPINEPHRINE (PRIMATENE MIST) at an unspecified dose and frequency and BISMUTH SUBSALICYLATE (PEPTOBISMOL) for Diarrhoea, at an unspecified dose and frequency. At the time of the report, ILLNESS (I'm still sick), DIARRHOEA (Diarrhoea), ASTHENIA (Weak), DYSPNOEA (Shortness of breath) and FAECES DISCOLOURED (Back, tarry stool.) had not resolved. Not Provided          Other concomitant product include blood thinners. Other treatment medications include nebulizer.  Action taken with mRNA-1273 in response to the events was  not applicable.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Headache, Nausea
Clinical narrative: feeling cold; Nausea; Chills; Headache; Fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.            Concomitant product use was not provided. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Added event onset date.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: feeling cold; Nausea; Chills; Headache; Fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING COLD (feeling cold), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache), PYREXIA (Fever) and FATIGUE (Tiredness) outcome was unknown.            Concomitant product use was not provided. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Added event onset date.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: fatigue; headache; This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Hypercholesterolemia. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for Hypercholesterolemia, ESTRADIOL (ESTROGEN) for Menopause.   On 14-Jan-2021 at 11:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021 at 11:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). On 18-Feb-2021, FATIGUE (fatigue) and HEADACHE (headache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-008584 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: Throat tightness; This spontaneous case was reported by a nurse and describes the occurrence of THROAT TIGHTNESS (Throat tightness) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced THROAT TIGHTNESS (Throat tightness). On 19-Mar-2021, THROAT TIGHTNESS (Throat tightness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. No treatment was reported.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Nurse states 2 doses were given to minors; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Nurse states 2 doses were given to minors) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Nurse states 2 doses were given to minors). On 13-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Nurse states 2 doses were given to minors) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant mediations were not provided.  Treatment information was not provided.  Patient is scheduled for 2nd dose on 10jun2021.   This case was linked to MOD-2021-211661 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Additional follow up information contains reporter details.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Therapeutic response unexpected
Clinical narrative: severe dizziness; feels stronger/having the will to get things done; severe tiredness that lasts for 20 minutes to an hour; severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (severe dizziness), THERAPEUTIC RESPONSE UNEXPECTED (feels stronger/having the will to get things done), FATIGUE (severe tiredness that lasts for 20 minutes to an hour) and HEADACHE (severe headaches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 011A21A) for COVID-19 vaccination.     Concomitant products included BISOPROLOL, CALCIUM and RISEDRONATE SODIUM (RISEDRONATE) for an unknown indication.   On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (severe dizziness), THERAPEUTIC RESPONSE UNEXPECTED (feels stronger/having the will to get things done), FATIGUE (severe tiredness that lasts for 20 minutes to an hour) and HEADACHE (severe headaches). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PREDNISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (severe dizziness), FATIGUE (severe tiredness that lasts for 20 minutes to an hour) and HEADACHE (severe headaches) had not resolved and THERAPEUTIC RESPONSE UNEXPECTED (feels stronger/having the will to get things done) outcome was unknown.            The patient was prescribed Ibuprofen, prednisone and unspecified antihistamines by the health care provider. The patient took ibuprofen for 5-6 days and antihistamines and prednisone did not help with the adverse events. Action taken with mRNA-1273 in response to the events was not applicable.    This case was linked to MOD-2021-211625 (Patient Link).
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID 4 days afterwards; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID 4 days afterwards) in a 5-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced COVID-19 (COVID 4 days afterwards). At the time of the report, COVID-19 (COVID 4 days afterwards) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Nausea, Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Severe stomach pain; Nauseous; Fever; My 15yr old daughter had her 2nd covid vaccine on 6/5; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (My 15yr old daughter had her 2nd covid vaccine on 6/5), ABDOMINAL PAIN UPPER (Severe stomach pain), NAUSEA (Nauseous) and PYREXIA (Fever) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (My 15yr old daughter had her 2nd covid vaccine on 6/5). On 07-Jun-2021, the patient experienced ABDOMINAL PAIN UPPER (Severe stomach pain), NAUSEA (Nauseous) and PYREXIA (Fever). On 05-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (My 15yr old daughter had her 2nd covid vaccine on 6/5) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Severe stomach pain), NAUSEA (Nauseous) and PYREXIA (Fever) outcome was unknown.            No concomitant medications were reported No laboratory data was provided. No treatment information was provided.   This case was linked to MOD-2021-246755 (Patient Link).   Reporter did not allow further contact
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna Vaccine on is 16/ Nurse states 2 doses were given to minors; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna Vaccine on is 16/ Nurse states 2 doses were given to minors) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna Vaccine on is 16/ Nurse states 2 doses were given to minors). On 13-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna Vaccine on is 16/ Nurse states 2 doses were given to minors) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient is Scheduled for 2nd dose 10Jun2021.  No concomitant medication details were provided. No treatment medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Significant Follow up received. Initial Source document attached
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dyspnoea, Headache, Nausea, Oropharyngeal pain
Clinical narrative: mild headache; mild nausea; face and eyelids are swollen; face and eyelids are swollen; sore throat; shortness of breath; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (mild headache), NAUSEA (mild nausea), SWELLING FACE (face and eyelids are swollen), SWELLING OF EYELID (face and eyelids are swollen) and OROPHARYNGEAL PAIN (sore throat) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced HEADACHE (mild headache), NAUSEA (mild nausea), SWELLING FACE (face and eyelids are swollen), SWELLING OF EYELID (face and eyelids are swollen), OROPHARYNGEAL PAIN (sore throat) and DYSPNOEA (shortness of breath). The patient was treated with PARACETAMOL (TYLENOL) on 16-Apr-2021 at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) on 16-Apr-2021 at an unspecified dose and frequency. At the time of the report, HEADACHE (mild headache), NAUSEA (mild nausea), SWELLING FACE (face and eyelids are swollen), SWELLING OF EYELID (face and eyelids are swollen), OROPHARYNGEAL PAIN (sore throat) and DYSPNOEA (shortness of breath) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.4 (High) 100.4.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported .
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swelling of eyelid
Clinical narrative: mild headache; mild nausea; face and eyelids are swollen; face and eyelids are swollen; sore throat; shortness of breath; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (mild headache), NAUSEA (mild nausea), SWELLING FACE (face and eyelids are swollen), SWELLING OF EYELID (face and eyelids are swollen) and OROPHARYNGEAL PAIN (sore throat) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced HEADACHE (mild headache), NAUSEA (mild nausea), SWELLING FACE (face and eyelids are swollen), SWELLING OF EYELID (face and eyelids are swollen), OROPHARYNGEAL PAIN (sore throat) and DYSPNOEA (shortness of breath). The patient was treated with PARACETAMOL (TYLENOL) on 16-Apr-2021 at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) on 16-Apr-2021 at an unspecified dose and frequency. At the time of the report, HEADACHE (mild headache), NAUSEA (mild nausea), SWELLING FACE (face and eyelids are swollen), SWELLING OF EYELID (face and eyelids are swollen), OROPHARYNGEAL PAIN (sore throat) and DYSPNOEA (shortness of breath) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.4 (High) 100.4.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported .
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: a little pain in the shoulder; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (a little pain in the shoulder) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (a little pain in the shoulder). At the time of the report, ARTHRALGIA (a little pain in the shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Administered 1st Dose to a 17 Year Old; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered 1st Dose to a 17 Year Old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered 1st Dose to a 17 Year Old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Administered 1st Dose to a 17 Year Old) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported No treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Follow-up information received on 10-JUN-2021 contains non-significant information.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Mobility decreased, Myalgia, Paraesthesia
Clinical narrative: experiencing tingling in legs and problem getting up with muscles; problem getting up with muscles; Sore arm; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PARAESTHESIA (experiencing tingling in legs and problem getting up with muscles), MOBILITY DECREASED (problem getting up with muscles) and MYALGIA (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 038K20A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (Sore arm). On 02-Apr-2021, the patient experienced PARAESTHESIA (experiencing tingling in legs and problem getting up with muscles) and MOBILITY DECREASED (problem getting up with muscles). On 27-Feb-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (Sore arm) had resolved. At the time of the report, PARAESTHESIA (experiencing tingling in legs and problem getting up with muscles) and MOBILITY DECREASED (problem getting up with muscles) had not resolved.            No treatment details were reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Feeding disorder
Clinical narrative: fatigue; nausea; Did not eat and drink; Diarrhea; Joints Pain; Muscle Pain; Headache; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (Did not eat and drink), DIARRHOEA (Diarrhea), ARTHRALGIA (Joints Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced FEEDING DISORDER (Did not eat and drink), DIARRHOEA (Diarrhea), ARTHRALGIA (Joints Pain), MYALGIA (Muscle Pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced FATIGUE (fatigue) and NAUSEA (nausea). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 12-Apr-2021, FEEDING DISORDER (Did not eat and drink), DIARRHOEA (Diarrhea), ARTHRALGIA (Joints Pain), MYALGIA (Muscle Pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) was resolving. At the time of the report, FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Non-significant follow-up appended.NNI
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: fatigue; nausea; Did not eat and drink; Diarrhea; Joints Pain; Muscle Pain; Headache; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (Did not eat and drink), DIARRHOEA (Diarrhea), ARTHRALGIA (Joints Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced FEEDING DISORDER (Did not eat and drink), DIARRHOEA (Diarrhea), ARTHRALGIA (Joints Pain), MYALGIA (Muscle Pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced FATIGUE (fatigue) and NAUSEA (nausea). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 12-Apr-2021, FEEDING DISORDER (Did not eat and drink), DIARRHOEA (Diarrhea), ARTHRALGIA (Joints Pain), MYALGIA (Muscle Pain), HEADACHE (Headache), PYREXIA (Fever) and CHILLS (Chills) was resolving. At the time of the report, FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 10-Jun-2021: Non-significant follow-up appended.NNI
Sex: U
Vaccine: COVID19
Symptoms: Aphonia, Throat irritation
Clinical narrative: lost my voice; throat is on fire; This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (lost my voice) and THROAT IRRITATION (throat is on fire) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APHONIA (lost my voice) and THROAT IRRITATION (throat is on fire). At the time of the report, APHONIA (lost my voice) and THROAT IRRITATION (throat is on fire) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.    Reporter did not allow further contact
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Feeling hot, Pain in extremity, Rhinorrhoea, Urticaria
Clinical narrative: warm palm; Bumps on both hands; Right foot bumps; Bumps on wrist; Arm soreness; Runny nose; Taste metallic; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), RHINORRHOEA (Runny nose), DYSGEUSIA (Taste metallic), URTICARIA (Bumps on wrist) and FEELING HOT (warm palm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy and Drug allergy (Allergic to morphine.). Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, METFORMIN for Diabetes mellitus, LISINOPRIL for Hypertension, NORTRIPTYLINE for Nerve pain, BRIVARACETAM (BRIVIACT), PHENOBARBITAL and TOPIRAMATE (TROKENDI XR) for Seizure, FUROSEMIDE (LASIX [FUROSEMIDE]) for Water retention, VITAMIN D NOS and ASCORBIC ACID (VITAMINS C) for an unknown indication.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness), RHINORRHOEA (Runny nose) and DYSGEUSIA (Taste metallic). On 15-Apr-2021, the patient experienced URTICARIA (Bumps on wrist). On 17-Apr-2021, the patient experienced FEELING HOT (warm palm), URTICARIA (Bumps on both hands) and URTICARIA (Right foot bumps). At the time of the report, PAIN IN EXTREMITY (Arm soreness), RHINORRHOEA (Runny nose), DYSGEUSIA (Taste metallic), URTICARIA (Bumps on wrist), FEELING HOT (warm palm), URTICARIA (Bumps on both hands) and URTICARIA (Right foot bumps) outcome was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Headache
Clinical narrative: shaking / shaking legs; Pain in arm; headache; pain in the shoulder; chills; nausea; fever (100.5°F); extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder) and CHILLS (chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder), CHILLS (chills), NAUSEA (nausea), PYREXIA (fever (100.5°F)) and FATIGUE (extremely tired). At the time of the report, TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder), CHILLS (chills), NAUSEA (nausea), PYREXIA (fever (100.5°F)) and FATIGUE (extremely tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.5 (High) 100.5F.         Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Tremor
Clinical narrative: shaking / shaking legs; Pain in arm; headache; pain in the shoulder; chills; nausea; fever (100.5°F); extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder) and CHILLS (chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder), CHILLS (chills), NAUSEA (nausea), PYREXIA (fever (100.5°F)) and FATIGUE (extremely tired). At the time of the report, TREMOR (shaking / shaking legs), PAIN IN EXTREMITY (Pain in arm), HEADACHE (headache), ARTHRALGIA (pain in the shoulder), CHILLS (chills), NAUSEA (nausea), PYREXIA (fever (100.5°F)) and FATIGUE (extremely tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Body temperature: 100.5 (High) 100.5F.         Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Periorbital swelling, Pruritus
Clinical narrative: Puffy eyes; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PERIORBITAL SWELLING (Puffy eyes) and PRURITUS (Itching) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced PERIORBITAL SWELLING (Puffy eyes) and PRURITUS (Itching). At the time of the report, PERIORBITAL SWELLING (Puffy eyes) and PRURITUS (Itching) outcome was unknown.            Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in right leg below the knee; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in right leg below the knee) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in right leg below the knee). At the time of the report, PAIN IN EXTREMITY (pain in right leg below the knee) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills
Clinical narrative: Tightness of chest; Chills that come and go; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tightness of chest) and CHILLS (Chills that come and go) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced CHEST DISCOMFORT (Tightness of chest) and CHILLS (Chills that come and go). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Tightness of chest) outcome was unknown and CHILLS (Chills that come and go) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant medications include inhaler. Patient wants to know if she can use inhaler as she did not use it for a longer time.
Sex: U
Vaccine: COVID19
Symptoms: Lymphocyte count, Lymphocyte count increased
Clinical narrative: High absolute lymphocyte count; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOCYTE COUNT INCREASED (High absolute lymphocyte count) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHOCYTE COUNT INCREASED (High absolute lymphocyte count). At the time of the report, LYMPHOCYTE COUNT INCREASED (High absolute lymphocyte count) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Lymphocyte count: increased (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant product use was reported. No treatment information was provided.  The reporter asked whether COVID-19 vaccine cause a high absolute lymphocyte count 21 days after the second dose.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Hypoaesthesia
Clinical narrative: Lost sense of taste and smell; Started to feel numb; Lost sense of taste and smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost sense of taste and smell), HYPOAESTHESIA (Started to feel numb) and ANOSMIA (Lost sense of taste and smell) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, the patient experienced AGEUSIA (Lost sense of taste and smell), HYPOAESTHESIA (Started to feel numb) and ANOSMIA (Lost sense of taste and smell). At the time of the report, AGEUSIA (Lost sense of taste and smell), HYPOAESTHESIA (Started to feel numb) and ANOSMIA (Lost sense of taste and smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  Treatment information was not provided.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Erythema, Feeling hot, Myalgia, Peripheral swelling
Clinical narrative: have soreness in her arms; she was dehydrated; legs have a rash,left one is slightly worse; more swollen than the right leg; left leg is also more red; warm than the right leg; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (have soreness in her arms), DEHYDRATION (she was dehydrated), RASH (legs have a rash,left one is slightly worse), PERIPHERAL SWELLING (more swollen than the right leg) and ERYTHEMA (left leg is also more red) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] and ESTRADIOL (ESTRACE) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (have soreness in her arms), DEHYDRATION (she was dehydrated), RASH (legs have a rash,left one is slightly worse), PERIPHERAL SWELLING (more swollen than the right leg), ERYTHEMA (left leg is also more red) and FEELING HOT (warm than the right leg). The patient was treated with NYSTATIN at a dose of 1 dosage form; GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) at a dose of 1 dosage form; COCONUT OIL at a dose of 1 dosage form; EUCALYPTUS OIL at a dose of 1 dosage form and CANNABIDIOL (CBD OIL) at a dose of 1 dosage form. At the time of the report, MYALGIA (have soreness in her arms), DEHYDRATION (she was dehydrated), RASH (legs have a rash,left one is slightly worse), PERIPHERAL SWELLING (more swollen than the right leg), ERYTHEMA (left leg is also more red) and FEELING HOT (warm than the right leg) outcome was unknown. Not Provided